Erica Bello

751 total citations · 1 hit paper
7 papers, 382 citations indexed

About

Erica Bello is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Erica Bello has authored 7 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Hematology and 2 papers in Genetics. Recurrent topics in Erica Bello's work include CRISPR and Genetic Engineering (2 papers), Acute Myeloid Leukemia Research (1 paper) and Genetic Associations and Epidemiology (1 paper). Erica Bello is often cited by papers focused on CRISPR and Genetic Engineering (2 papers), Acute Myeloid Leukemia Research (1 paper) and Genetic Associations and Epidemiology (1 paper). Erica Bello collaborates with scholars based in United Kingdom, United States and Spain. Erica Bello's co-authors include Andrew Bassett, Sarah Cooper, Jeremy Schwartzentruber, Daniel J. Gaffney, Natsuhiko Kumasaka, Robin J.M. Franklin, Karol Estrada, Pedro Beltrão, Inigo Barrio‐Hernandez and Adam M. H. Young and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Nature Genetics.

In The Last Decade

Erica Bello

7 papers receiving 378 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer’s disease risk genes

2021 280 citations Jeremy Schwartzentruber, Sarah Cooper et al. Nature Genetics profile →

Peers

Countries citing papers authored by Erica Bello

Since Specialization

Citations

This map shows the geographic impact of Erica Bello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erica Bello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erica Bello more than expected).

Fields of papers citing papers by Erica Bello

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erica Bello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erica Bello. The network helps show where Erica Bello may publish in the future.

Co-authorship network of co-authors of Erica Bello

This figure shows the co-authorship network connecting the top 25 collaborators of Erica Bello. A scholar is included among the top collaborators of Erica Bello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erica Bello. Erica Bello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Robust temporal map of human in vitro myelopoiesis using single-cell genomics 2022 ·Nature Communications ·Clara Alsinet, (unknown), Valentina Lorenzi, Erica Bello, Iva Kelava, Carla P. Jones, Roser Vilarrasa‐Blasi, Carmen Sancho‐Serra, Andrew Knights, Jong-Eun Park, (unknown), Gosia Trynka, David F. Tough, Andrew Bassett, Daniel J. Gaffney, Damiana Álvarez‐Errico, Roser Vento‐Tormo	13
2	Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer’s disease risk genes breakdown → 2021 ·Nature Genetics ·Jeremy Schwartzentruber, Sarah Cooper, Jimmy Z. Liu, Inigo Barrio‐Hernandez, Erica Bello, Natsuhiko Kumasaka, Adam M. H. Young, Robin J.M. Franklin, Toby Johnson, Karol Estrada, Daniel J. Gaffney, Pedro Beltrão, Andrew Bassett	280
3	Author Correction: Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer’s disease risk genes 2021 ·Nature Genetics ·Jeremy Schwartzentruber, Sarah Cooper, Jimmy Z. Liu, Inigo Barrio‐Hernandez, Erica Bello, Natsuhiko Kumasaka, Adam M. H. Young, Robin J.M. Franklin, Toby Johnson, Karol Estrada, Daniel J. Gaffney, Pedro Beltrão, Andrew Bassett	7
4	Screening for functional transcriptional and splicing regulatory variants with GenIE 2020 ·Nucleic Acids Research ·Sarah Cooper, Jeremy Schwartzentruber, Erica Bello, Eve L. Coomber, Andrew Bassett	9
5	CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q) 2015 ·British Journal of Haematology ·Erica Bello, Andrea Pellagatti, Jacqueline Shaw, Cristina Mecucci, Rajko Kušec, Sally Killick, Aristoteles Giagounidis, Sophie Raynaud, Marı́a José Calasanz, Pierre Fenaux, Jacqueline Boultwood	17
6	ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts 2015 ·Oncotarget ·Simona Valletta, Hamid Dolatshad, Matthias Bartenstein, Bon Ham Yip, Erica Bello, Shanisha Gordon, Yiting Yu, Jacqueline Shaw, Swagata Roy, Laura Scifo, Anna Schuh, Andrea Pellagatti, Tudor A. Fulga, Amit Verma, Jacqueline Boultwood	54
7	Phase II Trial of Syncopated Thalidomide, Lenalidomide, and Weekly Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma 2012 ·Clinical Lymphoma Myeloma & Leukemia ·(unknown), David S. Siegel, Laura McBride, Elizabeth Bilotti, Erica Bello, (unknown), (unknown), (unknown), Ann McNeill, David H. Vesole	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact